Patent intelligence · US
US 8268792
Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
Patent details — US 8268792
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 18, 2012
- Expiration
- Sep 13, 2032
- Applicant
- Reinhard Rettenberger
- Claims
- 10
- CPC classes
- A61K, A61K31/085, A61K31/7034, A61K36/15
Quick answer
US 8268792 (Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases) is held by Reinhard Rettenberger. Status: granted. Granted Sep 18, 2012. Expires Sep 13, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Reinhard Rettenberger
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K31/085, A61K31/7034, A61K36/15, A61K36/481, A61K36/482
More from Reinhard Rettenberger
Related pharmaceutical patents in our USPTO index.
-
US 12390512
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
granted -
US 11033623
Magnetic stem cell therapy for lesions
granted -
US 10472381
Sialic acid derivatives
granted -
US 10265396
Magnetic extracellular matrix
granted -
US 9539228
Composition containing lysine as a nutritional supplement or treatment in the case of herpes
granted -
US 8309071
Foamy viral envelope genes
granted -
US 8293803
Retinoid compounds and their use
granted
Frequently asked questions
What is US patent 8268792?
US 8268792 (Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases) is held by Reinhard Rettenberger. Status: granted. Granted Sep 18, 2012. Expires Sep 13, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8268792?
Reinhard Rettenberger is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 11 pharmaceutical patents for this assignee.
When does US 8268792 expire?
Our index shows an expiration date of Sep 13, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.